Particle.news
Download on the App Store
9 ARTICLES
·
2w ago

Roche Announces $50 Billion U.S. Investment in Response to Tariff Concerns

The pharmaceutical giant's five-year plan includes new R&D hubs, expanded manufacturing, and over 12,000 jobs as the industry braces for potential White House tariffs.

Roche is attempting to placate Trump in his trade vendetta.
Image
Image
Image

Overview

  • Roche has committed $50 billion to expand its U.S. operations over the next five years, marking one of the largest investments in the pharmaceutical sector.
  • The company plans to create more than 12,000 jobs, with 1,000 directly at Roche and the rest supporting new manufacturing facilities.
  • Key investments include new R&D hubs in Massachusetts, focusing on AI and advanced treatments, and expanded manufacturing sites in Indiana, Pennsylvania, and California.
  • A 900,000 square-foot manufacturing center will be built to support Roche’s next-generation weight loss medicine portfolio.
  • Once the new facilities are operational, Roche expects to export more medicines from the U.S. than it imports, signaling a shift in its supply chain strategy.